A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...

The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...

Telehealth prescribing of stimulants for teens and adults with ADHD is not linked to a higher risk for substance use disorder vs in-person prescribing, a new study shows.

Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience ...

While ADHD medications continue to reduce the risk for self-harm, injury, and car crashes, recent expanded prescribing ...

People with ADHD often struggle with executive function, which Didier describes as “your brain’s GPS” for navigating your day ...

Figures suggest adults with ADHD are five times more likely to try to take their own lives than those without it. | ITV News ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...